Urology – September 30, 2016 – Vol. 34 – No. 7
Article Reviewed: Efficacy and Safety of Mirabegron Add-On Therapy to Solifenacin in Incontinent Overactive Bladder Patients With an Inadequate Response to Initial 4-Week Solifenacin Monotherapy: A Randomised Double-Blind Multicentre Phase 3B Study (BESIDE). Drake MJ, Chapple C, et al: Eur Urol; 2016;70 (July): 136-145.
Interstitial cystitis (IC) is a chronic health condition that causes pain and pressure in the bladder and pelvic area. Because of this, it is sometimes called painful bladder syndrome. IC can cause an urgent need to urinate, a frequent need to urinate, or both…Read More
Christie Woodruff our Nurse Practitioner Discusses IC on the Radio
Questions?
